Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri ATCC PTA 5289 and Reduced Plaque Index

Doses used in studies
  • CFU/day: 216 (median 216, IQR 216216) 1 study
2 of 2 papers
Back to top